about
pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and releaseASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanismThe candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).Gut mucosal healing: is the science relevant?Oxygen-sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiologyCatabolic stress induces expression of hypoxia-inducible factor (HIF)-1 alpha in articular chondrocytes: involvement of HIF-1 alpha in the pathogenesis of osteoarthritisThe clinical utility of aflibercept for diabetic macular edemaRoles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degenerationMechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets.Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesisHIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemiaDeletion of von Hippel-Lindau protein converts renin-producing cells into erythropoietin-producing cells.Systems biology of pro-angiogenic therapies targeting the VEGF systemDevelopmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau diseaseUse of culture geometry to control hypoxia-induced vascular endothelial growth factor secretion from adipose-derived stem cells: optimizing a cell-based approach to drive vascular growthRoles of vascular endothelial growth factor in amyotrophic lateral sclerosis.Crosstalk between the DNA damage response, histone modifications and neovascularisation.The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.Pharmacodynamic and pharmacokinetic assessment of pulmonary rehabilitation mixture for the treatment of pulmonary fibrosisPRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.Epigenetic control of hypoxia inducible factor-1α-dependent expression of placental growth factor in hypoxic conditions.Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction.Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS.Critical appraisal of ranibizumab in the treatment of diabetic macular edema.Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.Low glucose microenvironment of normal kidney cells stabilizes a subset of messengers involved in angiogenesis.Age related vascular endothelial function following lifelong sedentariness: positive impact of cardiovascular conditioning without further improvement following low frequency high intensity interval training.Roles of main pro- and anti-angiogenic factors in tumor angiogenesisPivotal role of vascular endothelial growth factor pathway in tumor angiogenesis.Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner.Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stressHypoxic preconditioning protects against ischemic brain injury.STAT3 can serve as a hit in the process of malignant transformation of primary cells.New vectors and strategies for cardiovascular gene therapy.New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genesInsulin-like growth factor I is required for vessel remodeling in the adult brainNanoparticle Delivered VEGF-A siRNA Enhances Photodynamic Therapy for Head and Neck Cancer Treatment
P2860
Q24298247-DB3B78CE-BB91-41E7-92CF-6C5C33292588Q24320200-5A9E6167-6C61-461D-A1FF-B29A5D50C707Q24529065-2D2CE2E4-D7CD-427C-89D3-C88A1A3CA683Q24669693-66A3D5F1-A133-4997-9369-4BFF539401EFQ24802444-DE37D83C-BFEB-42F4-9E35-43BE91E3AC2DQ24810433-8F6F566D-5F8A-43DA-8996-4A6BA44AF7CFQ26783575-BEB171A8-7097-44DE-8B47-0B928E98B823Q27012739-249829AC-CA42-47DA-A897-CCD7C3BF2FBEQ27919668-B382A90C-9B18-48A3-8D57-F04F5E8C80AFQ28252815-92940AE4-D7F2-4006-AB80-6596C71CF7B9Q28474375-5904FE37-D647-4827-851F-CD8FFFC02361Q30414664-48791A00-894C-49CD-BAF5-CBD82D1DE1BFQ30430112-39438318-4EA3-4F6A-BA9C-90E6C9E6D2B5Q30430557-4E0E6812-4473-4E39-97ED-27081210F652Q30554316-0B34CF5C-D7F4-4E7D-AAF5-242583F6993EQ33616384-8E2744D6-16B0-4FF8-B2C3-6AB2F0796BD5Q33639330-10D2D904-8C78-4CBE-A7FB-A752FDE7A72BQ33673803-4E49DC78-9CBC-421C-B5B9-2EB143C25D4DQ33679929-158AF22F-67FD-4C36-A2DB-C5A7F9259BA7Q33799369-18A34971-ACE5-4689-931B-0A24D45933FEQ33826204-990C82E0-2B1B-4589-9EC1-19711B68BEDDQ34000432-9897414D-D5A5-4903-BE9E-FDCF57F00369Q34137672-66D68848-B40E-46D3-A79C-D3F22B3506B2Q34424910-D0F98116-06AA-4763-B570-1BB289606BB9Q34450007-2608A8B2-069B-4AB4-9174-7BDDCA433546Q34803171-825D0C67-91EB-4C2F-AA2E-158BB70D02A2Q35058837-D2478EF3-28F1-432C-B2EB-69441EA5B41DQ35247687-3A997A52-B19C-4F1E-9393-A2A6FC05E780Q35294298-B9C682D5-FA51-4DF6-A53E-184E36DEADFFQ35294370-ECBDE4F7-F623-4D64-987C-58CF79FA3064Q35668936-972386A8-71F8-498B-868B-C831528C0D3AQ35782469-0AF6068B-0401-4648-98B8-D5113D03B2F0Q35856898-B2089B99-C820-4EF7-BCA3-CAB582341162Q35858632-B6712920-6BBE-48D0-9C77-70421BE4470AQ36045209-FC7CF4E2-95F8-44BC-A730-6F219D0947E4Q36084487-66D9F96A-E05F-45D7-916A-DDCFF0A58F9AQ36174173-B48339FB-C9D0-41AB-8BED-036DCF9365FDQ36385632-953413C3-A7B4-4A61-8515-8086B66037F9Q36449180-9E12CFE3-B96A-42E7-A07A-2FFCB3395AF2Q36582823-660F954C-E7A5-4823-B430-134A65B541E5
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Oxygen sensors and angiogenesis.
@ast
Oxygen sensors and angiogenesis.
@en
Oxygen sensors and angiogenesis.
@nl
type
label
Oxygen sensors and angiogenesis.
@ast
Oxygen sensors and angiogenesis.
@en
Oxygen sensors and angiogenesis.
@nl
prefLabel
Oxygen sensors and angiogenesis.
@ast
Oxygen sensors and angiogenesis.
@en
Oxygen sensors and angiogenesis.
@nl
P356
P1476
Oxygen sensors and angiogenesis.
@en
P2093
Patrick H Maxwell
P356
10.1006/SCDB.2001.0287
P577
2002-02-01T00:00:00Z